Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myelomonocytic, Chronic × prednylidene × 30 days × Clear all

Sponsor

Conditions

Burkitt Lymphoma 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Lymphoma, Large B-Cell, Diffuse 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Leukemia, Biphenotypic, Acute 3 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2 Prostatic Neoplasms 1 Melanoma 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma, AIDS-Related 1 Lymphoma 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Leukemia, Myeloid, Accelerated Phase 1 HTLV-I Infections 1 Down Syndrome 1 Carcinoma, Merkel Cell 1 Carcinoma, Basal Cell 1 Blastic Plasmacytoid Dendritic Cell Neoplasm 1 Blast Crisis 1 Ann Arbor Stage II Mantle Cell Lymphoma 1

Interventions

Azacitidine 7 venetoclax 4 Injections 3 Decitabine 3 Biopsy 3 decitabine and cedazuridine drug combination 2 cedazuridine 2 Vorinostat 2 Tacrolimus 2 Specimen Handling 2 Lenalidomide 2 Cytarabine 2 Carboplatin 2 veliparib 1 tagraxofusp 1 seclidemstat 1 ruxolitinib 1 quizartinib 1 olutasidenib 1 gilteritinib 1 fludarabine phosphate 1 fludarabine 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 canakinumab 1 auricularum 1 X-Rays 1 Whole-Body Irradiation 1 Transplantation 1 Topotecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡